Free Trial

Warby Parker (WRBY) Competitors

Warby Parker logo
$20.12 -0.11 (-0.54%)
Closing price 03/25/2025 03:58 PM Eastern
Extended Trading
$20.16 +0.04 (+0.22%)
As of 03/25/2025 05:40 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

WRBY vs. STVN, GKOS, BLCO, INSP, NARI, IRTC, PRCT, NVST, TMDX, and SLNO

Should you be buying Warby Parker stock or one of its competitors? The main competitors of Warby Parker include Stevanato Group (STVN), Glaukos (GKOS), Bausch + Lomb (BLCO), Inspire Medical Systems (INSP), Inari Medical (NARI), iRhythm Technologies (IRTC), PROCEPT BioRobotics (PRCT), Envista (NVST), TransMedics Group (TMDX), and Soleno Therapeutics (SLNO). These companies are all part of the "medical equipment" industry.

Warby Parker vs.

Warby Parker (NYSE:WRBY) and Stevanato Group (NYSE:STVN) are both mid-cap consumer staples companies, but which is the superior business? We will compare the two companies based on the strength of their earnings, analyst recommendations, institutional ownership, community ranking, media sentiment, dividends, profitability, valuation and risk.

Warby Parker has a beta of 1.91, meaning that its stock price is 91% more volatile than the S&P 500. Comparatively, Stevanato Group has a beta of 0.6, meaning that its stock price is 40% less volatile than the S&P 500.

93.2% of Warby Parker shares are owned by institutional investors. 26.5% of Warby Parker shares are owned by company insiders. Comparatively, 0.7% of Stevanato Group shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

Stevanato Group has a net margin of 10.47% compared to Warby Parker's net margin of -4.39%. Stevanato Group's return on equity of 9.86% beat Warby Parker's return on equity.

Company Net Margins Return on Equity Return on Assets
Warby Parker-4.39% -8.26% -4.37%
Stevanato Group 10.47%9.86%5.79%

Warby Parker presently has a consensus price target of $23.43, indicating a potential upside of 16.44%. Given Warby Parker's higher probable upside, research analysts clearly believe Warby Parker is more favorable than Stevanato Group.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Warby Parker
0 Sell rating(s)
6 Hold rating(s)
9 Buy rating(s)
1 Strong Buy rating(s)
2.69
Stevanato Group
0 Sell rating(s)
2 Hold rating(s)
5 Buy rating(s)
0 Strong Buy rating(s)
2.71

Warby Parker received 14 more outperform votes than Stevanato Group when rated by MarketBeat users. However, 62.50% of users gave Stevanato Group an outperform vote while only 43.56% of users gave Warby Parker an outperform vote.

CompanyUnderperformOutperform
Warby ParkerOutperform Votes
44
43.56%
Underperform Votes
57
56.44%
Stevanato GroupOutperform Votes
30
62.50%
Underperform Votes
18
37.50%

In the previous week, Warby Parker had 2 more articles in the media than Stevanato Group. MarketBeat recorded 10 mentions for Warby Parker and 8 mentions for Stevanato Group. Stevanato Group's average media sentiment score of 1.21 beat Warby Parker's score of 0.65 indicating that Stevanato Group is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Warby Parker
5 Very Positive mention(s)
0 Positive mention(s)
5 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Stevanato Group
7 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Stevanato Group has higher revenue and earnings than Warby Parker. Warby Parker is trading at a lower price-to-earnings ratio than Stevanato Group, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Warby Parker$771.32M2.70-$63.20M-$0.17-118.35
Stevanato Group$1.10B5.83$157.62M$0.4844.29

Summary

Stevanato Group beats Warby Parker on 11 of the 19 factors compared between the two stocks.

Remove Ads
Get Warby Parker News Delivered to You Automatically

Sign up to receive the latest news and ratings for WRBY and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

WRBY vs. The Competition

MetricWarby ParkerOphthalmic goods IndustryStaples SectorNYSE Exchange
Market Cap$2.08B$11.13B$16.73B$19.75B
Dividend YieldN/A0.96%2.86%3.75%
P/E Ratio-74.5235.6416.1834.05
Price / Sales2.703.402.5128.57
Price / CashN/A14.5316.3917.54
Price / Book6.532.796.754.63
Net Income-$63.20M$224.27M$731.75M$1.02B
7 Day Performance12.88%1.25%-0.02%1.12%
1 Month Performance-11.49%-3.61%2.91%-1.07%
1 Year Performance55.49%-15.80%3.77%7.08%

Warby Parker Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
WRBY
Warby Parker
2.8057 of 5 stars
$20.12
-0.5%
$23.43
+16.4%
+55.5%$2.08B$771.32M-74.523,491Positive News
STVN
Stevanato Group
1.6784 of 5 stars
€20.71
+3.4%
N/A-32.3%$6.27B$1.10B44.065,635Positive News
GKOS
Glaukos
4.5422 of 5 stars
$103.12
+0.9%
$163.25
+58.3%
+20.4%$5.83B$383.48M-35.93780Positive News
BLCO
Bausch + Lomb
3.7687 of 5 stars
$15.39
+0.3%
$20.00
+29.9%
-4.1%$5.43B$4.79B-16.9212,500
INSP
Inspire Medical Systems
4.7022 of 5 stars
$166.59
+2.7%
$228.82
+37.4%
-19.4%$4.94B$802.80M96.291,246Positive News
NARI
Inari Medical
1.0467 of 5 stars
$79.97
flat
$68.00
-15.0%
N/A$4.68B$493.63M-59.24800
IRTC
iRhythm Technologies
1.5315 of 5 stars
$103.70
+3.0%
$119.73
+15.5%
-5.4%$3.26B$591.84M-28.491,790Positive News
Gap Up
PRCT
PROCEPT BioRobotics
3.0638 of 5 stars
$59.03
+2.4%
$94.29
+59.7%
+33.0%$3.24B$224.50M-30.27430News Coverage
NVST
Envista
4.1337 of 5 stars
$17.16
+3.0%
$20.18
+17.6%
-16.8%$2.95B$2.51B-2.6412,700
TMDX
TransMedics Group
3.0433 of 5 stars
$67.69
-1.2%
$122.70
+81.3%
-0.4%$2.28B$441.54M72.01210
SLNO
Soleno Therapeutics
4.4362 of 5 stars
$49.63
+0.6%
$71.20
+43.5%
+20.1%$2.28BN/A-14.9530Positive News
Remove Ads

Related Companies and Tools


This page (NYSE:WRBY) was last updated on 3/26/2025 by MarketBeat.com Staff
From Our Partners